Affinity labels for .beta.-adrenoceptors: preparation and properties of alkylating .beta.-blockers derived from indole
- 1 April 1987
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 30 (4) , 612-615
- https://doi.org/10.1021/jm00387a005
Abstract
New alkylating ligands derived from indole with high affinity for .beta.-adrenoceptors were synthesized and their properties examined. N8-(Bromoacetyl)-N1-[3-(4-indolyloxy)-2-hydroxypropyl]-(Z)-1,8-diamino-p-methane (8) and its N1,N8 isomer (9) were prepared by the reaction of bromoacetyl bromide with a product of the condensation of 4-indolyl glycidyl ether with (Z)-1,8-diamino-p-methane. A similiar reaction employing 2-cyano-4-indolyl glycidyl ether yielded the respective cyano derivatives 10 and 11. Apparent affinities (Ki,M) for .beta.-adrenoceptors on membrane preparations from rat heart and lung were 4.6 .times. 10-10 and 1.34 .times. 10-9 for 8, 2.3 .times. 10-8 and 4.5 .times. 10-9 for 9, 6.1 .times. 10-10 and 1.49 .times. 10-9 for 10, and 1.83 .times. 10-9 and 2.78 .times. 10-9 for 11, respectively. When membranes were preincubated with the above ligands (1 .times. 10-8 M, 30 min, 30.degree.C) and then washed extensively, reduction in the concentration of specific binding sites of [3H]dihydroalprenolol ranged from 7% to 76% and there was no change in KD of the remaining binding sites. (.+-.)-Alprenolol and (-)-isoproterenol, but not (+)-isoproterenol, when included with the alkaylating ligands in the preincubation mixtures, prevented the reduction in concentration of [3H]dihydroalprenolol binding sites. Compounds 8-11 alone did not stimulate adenylate cyclase activity in rat heart homogenates. However, these compounds inhibited (-)-isoproterenol-stimulated adenylate cyclase activity with Ki values ranging between 5 .times. 10-9 and 60 .times. 10-9M. These results suggest that high-affinity irreversible .beta.-adrenergic antagonists were obtained that may be useful for in vivo studies of .beta.-adrenoceptors.This publication has 9 references indexed in Scilit:
- Interactions of putatively irreversible antagonists with β1− and β2− adrenergic receptorsBiochemical Pharmacology, 1986
- EXPRESSION OF BETA-ADRENERGIC RECEPTORS IN SYNCHRONOUS AND ASYNCHRONOUS S49 LYMPHOMA-CELLS .1. RECEPTOR METABOLISM AFTER IRREVERSIBLE BLOCKADE OF RECEPTORS AND IN CELLS TRAVERSING THE CELL-DIVISION CYCLE1986
- Alkylating .beta.-blockers: activity of isomeric bromoacetyl alprenolol menthanesJournal of Medicinal Chemistry, 1985
- COVALENT LABELING OF THE BETA-ADRENERGIC LIGAND-BINDING SITE WITH PARA-(BROMOACETAMIDYL)BENZYLCARAZOLOL - A HIGHLY POTENT BETA-ADRENERGIC AFFINITY LABEL1985
- Irreversible blockade of ?-adrenergic receptors with a bromoacetyl derivative of pindololNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
- N‐Bromoacetyl‐amino‐cyanopindolol: a highly potent beta‐adrenergic affinity label blocks irreversibly a non‐protein component tightly associated with the receptorEuropean Journal of Biochemistry, 1985
- Is Ro 03-7894 an irreversible antagonist at β-adrenoceptor sites?British Journal of Pharmacology, 1984
- The effect of the beta-adrenoreceptor antagonist Ro03-7894 on rat atrial tension development and (−)-[3H]dihydroalprenolol binding to cardiac and lung membranesLife Sciences, 1983
- (±)[125Iodo]cyanopindolol, a new ligand for β-adrenoceptors: Identification and quantitation of subclasses of β-adrenoceptors in guinea pigNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981